DrugRisk Update: NuvaRing Blood Clot Trials Delayed As Claims Grow

Share Article

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

News Image
Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.

The birth control safety center at DrugRisk.com is announcing updated news for women using the contraceptive NuvaRing. After nearly 1,300 women filed a lawsuit alleging the devices caused blood clots, a federal judge has postponed the start of the first trial to January*.

DrugRisk was created to give those patients using popular prescription drugs and medical devices the latest information on safety alerts, recalls, studies and legal news. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.

The resource center has added warnings from health experts linking contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.

Due to the growing number of patients who have filed a NuvaRing lawsuit alleging blood clots, cases have been consolidated in a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. So far, 1,296 claims have been filed***.

Now, the resource center has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, recently entered an order postponing the start of the first trial from October 21 to January 27th*. DrugRisk is hopeful this will give the parties more time to reach a NuvaRing settlement.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Center or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*U.S. District Judge Rodney Sippel, 7/30/13; aboutlawsuits.com/wp-content/uploads/2013-07-30-NuvaRing-Order.pdf
**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
***JPML 7/10/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-July-10-2013.pdf

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website